Slide 1 of 15
Slide 1 - Risk-Based Containment Strategy
Risk-Based Containment Strategy
Case Study for Synthetic Molecule API Facility | ISPE, Nov-Dec 2025
---
Photo by Nastuh Abootalebi on Unsplash
Risk-Based Containment Strategy: HPAPI Facility Case Study
Generated from prompt:
Redesign and beautify a professional PowerPoint presentation titled "Risk-Based Containment Strategy – A Case Study for Synthetic Molecule API Facility (ISPE, Nov-Dec 2025)". Goals: - Modern, clean, high-end pharma/engineering style - Consistent color palette (deep blue, white, subtle teal accents) - Strong visual hierarchy, minimal text per slide - Use icons, diagrams, and data visualization where possible Slides structure: 1. Title Slide – bold, minimal, with subtitle 2. Why Containment Systems Matter – 4 pillars with icons (Work Safety, Product Quality, Regulatory Compliance, Cross-Contamination) 3. Regulatory Landscape – clean infographic style 4. Design & Verification Process – step-by-step diagram 5. Risk Assessment Framework (3 slides) – visual flow 6. Exposure Evaluation – factors + categories 7. Hierarchy of Controls – pyramid diagram 8. Risk Review & Verification Testing 9. FJ2 Facility Case Study – overview 10. FJ2 Case Study – processes + achievements (highlight award) 11. Risk Management Approach – early assessment + engineering controls 12. Implementation Results (2 slides) – charts/visual metrics 13. Performance Achievement – big numbers (<0.05 μg/m³, 100% compliance) 14. Continuous Improvement – before/after data visualization 15. Key Takeaways – clean summary with icons Enhancements: - Replace dense text with bullets (max 5 per slide) - Add consistent icons and section dividers - Emphasize key metrics visually - Improve grammar/wording where needed - Use whitespace and alignment for readability Output as a polished, client-ready presentation.
This presentation details a risk-based containment strategy for high-potency synthetic molecule API facilities, including regulatory compliance, risk assessment frameworks, exposure controls, hierarchy of controls, verification testing, and the FJ2施設
March 20, 202615 slides
Slide 2 of 15
Slide 2 - Why Containment Systems Matter
🛡️ Work Safety Ensuring robust protection for all personnel in high-potency environments.
✨ Product Quality Maintaining product integrity and prevent degradation.
📜 Regulatory Compliance Meeting stringent global regulatory requirements and standards.
🚫 Cross-Contamination Eliminating risks of potent molecule cross-contamination.
Slide 3 of 15
Slide 3 - Regulatory Landscape
- Focus on cGMP (Current Good Manufacturing Practice) alignment.
- Adherence to ISO 14644 (Cleanroom Standards).
- Safety standards for High-Potency Active Pharmaceutical Ingredients (HPAPI).
- Regular audits and validation protocols by international health authorities.
Slide 4 of 15
Slide 4 - Design & Verification Process
| 1. Assessment | 2. Strategy | 3. Validation | 4. Optimization |
|---|---|---|---|
| Identify hazardous substances and potential exposure points. | Apply risk-based containment design engineering. | Perform verification testing and safety assessments. | Continuous monitoring and improvement cycles. |
Slide 5 of 15
Slide 5 - Risk Assessment Framework Part 1
1
Risk Assessment Framework
Comprehensive evaluation of facility containment needs.
---
Photo by Tom Parkes on Unsplash
Slide 6 of 15
Slide 6 - Risk Assessment Framework Part 2
- Define scope and boundaries of the containment system.
- Identify critical potential release sources.
- Establish probability and severity matrices.
- Apply quantitative risk analysis techniques.
Slide 7 of 15
Slide 7 - Exposure Evaluation & Controls
- Exposure Factors: Frequency, duration, and quantity of handling.
- Categorization: Classifying molecules by potency (e.g., OEL 1-5).
- Containment Strategy: Matching technology to OEL levels.
- Verification: Ongoing monitoring of air quality metrics.
Slide 8 of 15
Slide 8 - Hierarchy of Controls
- Elimination/Substitution: Removing the hazard at source.
- Engineering Controls: Isolators, split butterfly valves, HVAC.
- Administrative Controls: SOPs, training, access restrictions.
- Personal Protective Equipment (PPE): Last line of defense.
Slide 9 of 15
Slide 9 - Risk Review & Verification Testing
- Routine periodic validation of seals and pressures.
- Particle count and air change efficacy testing.
- Safety interlock testing for isolator chambers.
- Corrective action plans for threshold exceedances.
Slide 10 of 15
Slide 10 - Case Study Overview
2
FJ2 Facility Case Study
High-performance synthetic molecule API facility.
---
Photo by Tom Parkes on Unsplash
Slide 11 of 15
Slide 11 - FJ2 Facility Achievements
- Integrated automated workflow for synthesis and filtration.
- Multi-stage RABS (Restricted Access Barrier Systems).
- Achieved industry-leading safety standards.
- Recognized with 2025 Pharma Facility Innovation Award.
Slide 12 of 15
Slide 12 - Risk Management Approach
- Early engagement with engineering/toxicology teams.
- Integration of containment equipment at design phase.
- Modular design for scalability and maintenance.
- Proactive identification of containment failures.
Slide 13 of 15
Slide 13 - Performance Achievement Metrics
- 50ng/m³: <0.05 μg/m³
- 100%: Compliance Rate
- 95%: Incident Reduction
Slide 14 of 15
Slide 14 - Continuous Improvement Comparison
Before Strategy Implementation
- Reliance on PPE only.
- High manual intervention.
- Frequent air threshold concerns.
- Limited real-time monitoring.
Post Strategy Implementation
- Advanced closed-loop isolation.
- Fully automated handling.
- <0.05 μg/m³ air quality.
- Real-time safety validation.
Slide 15 of 15
Slide 15 - Key Takeaways
Risk-based design ensures safety, efficiency, and compliance.
Summary for ISPE November 2025 presentation.
---
Photo by Nastuh Abootalebi on Unsplash
Discover More Presentations
Explore thousands of AI-generated presentations for inspiration
Powered by AI
Create Your Own Presentation
Generate professional presentations in seconds with Karaf's AI. Customize this presentation or start from scratch.